Hyundai Bio has ranked among the top searched stocks for 12 days in the past month.


As of 1:30 PM on the 24th, Hyundai Bio is trading at 21,200 KRW, down 16.37% from the previous day. This represents a 41.36% decline compared to December 22. Hyundai Bio is known as a manufacturer of bio cosmetics and display products.

Today, foreigners are tentatively recorded as net sellers of 4,122 shares. Over the past five days, individual investors have been net buyers of 232,639 shares, while foreigners and institutions have been net sellers of 99,259 shares and 74,107 shares, respectively.


On December 18, Hyundai Bio became a market issue with the news of a clinical trial outsourcing contract for an oral COVID-19 treatment, described as "continuous strength."



※Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing